Neurona Therapeutics Doses First Patient in Bilateral MTLE Trial of Regenerative Cell Therapy NRTX-1001

First patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date - - Trial funded...

June 19, 2025 | Thursday | News
Persica Secures EU Patent for PP353 Targeting Chronic Low Back Pain

Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic Low Back Pain (cLBP),...

June 12, 2025 | Thursday | News
SynaptixBio Advances First Clinical Candidate for Rare H-ABC Disease With Promising Antisense Oligonucleotide Therapy

SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the drug could halt disease progression and even rever...

June 11, 2025 | Wednesday | News
SOLVE FSHD and Modalis Partner to Advance CRISPR-Based Epigenome Editing Therapy for Muscular Dystrophy

-SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Ther...

June 09, 2025 | Monday | News
Liv Hospital and Istinye University Partner With University of Pennsylvania to Advance CAR T-Cell and Proton Therapy in Turkey

Liv Hospital and Istinye University have signed a comprehensive collaboration protocol with the University of Pennsylvania’s Perelman School of Medic...

May 27, 2025 | Tuesday | News
Applied StemCell Launches Hypoimmunogenic iPSC Tools to Accelerate Allogeneic Cell Therapy Development

Applied StemCell, a CRO/CDMO that blends unique genome editing technology and iPSC expertise, announced the launch of their first hypoimmunogenic hiPSC p...

May 21, 2025 | Wednesday | News
CellProthera Taps CELLforCURE by SEQENS to Manufacture First Clinical Batches of ProtheraCytes® by 2026

Manufacturing First clinical batches of ProtheraCytes® planned for 2026  CellProthera, a regenerative cell therapy developer specializing in isch...

May 21, 2025 | Wednesday | News
CellFE and Made Scientific Partner to Validate Scalable Non-Viral Gene Editing for T Cell Therapies

CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization...

May 14, 2025 | Wednesday | News
Azenta’s GENEWIZ and Form Bio Partner to Accelerate AAV Gene Therapy Development with Integrated Sequencing and AI Analysis

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. Azenta, Inc.a...

May 14, 2025 | Wednesday | News
PL BioScience and DewCell Introduce First Artificial Human Platelet Lysate Enabling Scalable Xeno-Free Cell Therapy Manufacturing

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceutical...

May 09, 2025 | Friday | News
Aspen Neuroscience Reports Positive 6-Month Data for ANPD001 in Parkinson’s Disease Ahead of IAPRD 2025 Presentation

ANPD001 was well tolerated with no major safety issues in low-dose cohort Patients showed early improvements in patient-reported and clinician-re...

May 08, 2025 | Thursday | News
Hovione and Firstgene Partner to Advance Precision Gene Therapy for Liver Cancer Using Novel AAV-Like Vector Platform

Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Car...

May 07, 2025 | Wednesday | News
Chengdu Origen and Vanotech Dose First Patient in Phase 1 Trial of KH658 Gene Therapy for Wet AMD

Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced  the first patient dosed ...

May 05, 2025 | Monday | News
Kytopen and Aldevron Partner to Streamline CRISPR T-Cell Engineering with Breakthrough Non-Viral Workflow

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organ...

May 01, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close